Digital Pathology Market
Digital Pathology Market - Global Industry Assessment & Forecast
#
Pages:
145
2022
Sep - 2023
VMR-1445
Segments Covered
By
Product Scanners, Software, Information management Software, Image Visualization & Analysis Software , Storage Systems
-
By
Type Human Pathology, Veterinary Pathology
-
By
Application Drug Discovery, Disease Diagnosis, Training & Education
-
By
End User Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories , Academic & Research Institutes
-
By
Region North America, Asia Pacific, Europe, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 825.70 Million |
 Revenue 2030:
|
USD 2164.20 Million |
 Revenue CAGR
(2023 - 2030): |
12.80% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Digital Pathology Market by Product by Type by Application by End User by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 12-Apr-2022
FAQ
Frequently Asked Question
What is the global demand for Digital Pathology in terms of revenue?
-
The global Digital Pathology valued at USD 825.70 Million in 2022 and is expected to reach USD 2164.20 Million in 2030 growing at a CAGR of 12.80%.
Which are the prominent players in the market?
-
The prominent players in the market are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN Inc. (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Aiforia Technologies Oy (Finland), Akoya Biosciences (US), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (US), Glencoe Software (US), Konfoong biotech international co. ltd. (China), Inspirata Inc. (US), PathAI (US), Proscia Inc. (US), Kanteron Systems (Spain), Mikroscan Technologies (US), Motic (US), Paige (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 12.80% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Digital Pathology include
- Increasing adoption of digital pathology to enhance lab efficiency
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Digital Pathology in 2022.
